America’s Cannabis Market Is Breaking Down. A Select Few Are Breaking Out

OG Article By Javier Hasse Watch Today's LIVE Episode on X and Rumble

and Youtube

October 08 2025

Overview

The U.S. cannabis sector, valued at $37 billion in 2021, has dropped to under $11 billion by October 7, 2025. Oversupply, falling prices, heavy debt, and stalled reforms hit hard. Yet, some operators grow through discipline and diversification.

Market Challenges

• Valuation Drop: Top firms (Curaleaf, Green Thumb, Tilray, Trulieve) lost over 70% of value since 2021.

• Price Decline: Average U.S. retail cannabis prices fell 32% since 2021, per Hoodie Analytics.

• Debt Burden: $3.8 billion in delinquent payments, averaging 6–7 weeks past due.

• Tax Pressure: IRS Code 280E limits deductions, straining cash flow.

• Hemp Uncertainty: Over 30 states restrict delta-8 THC; Congress may close the 2018 Farm Bill loophole in 2025.

Strategic Growth

• Sun Theory: Grew from $2.8M (2021) to $30M (2024), projecting $70M in 2025. Focuses on asset-light, brand-driven models. Ranked #644 on Inc. 5000 with 650% growth.

• Bud & Mary’s: Revenue rose from $9.3M (2020) to $24.8M (2024). Units sold doubled. Ranked #2 in Colorado sales by mid-2025.

• True Terpenes: Ancillary supplier powers $8B in products. Emphasizes innovation and reliability, with 0.7-day shipping on a 2-day SLA.

Public Operators

• Green Thumb Industries: $1.1B revenue in 2024, up 7.8%. Q2 2025 revenue at $293.3M, with $56M operating cash flow. Cash-flow positive.

• Trulieve: $1.2B revenue in 2024, up 5%. Q2 2025 revenue at $302M, with 62% gross margin. Growth is moderate.

• Vireo Growth: $99.4M revenue in 2024, up 15.4%. Acquired Deep Roots Harvest for $132.7M. Q2 2025 projects $90.7M revenue.

Policy Outlook

• Rescheduling: Moving cannabis to Schedule III could ease 280E, boosting retail profits by ~20%, per Seth Yakatan. Impact on MSOs is limited.

• Trump’s Stance: Reposted a Truth Social video on CBD, hinting at health-focused reform. Stocks spiked.

• Hemp Debate: Regulatory clarity on hemp-derived THC may wait until 2025 Farm Bill.

Expert Insights

• Seth Yakatan: Mergers won’t save operators. De-leveraging and profitable growth are key. Sees 50–100% upside with federal reform.

• Sandy Li: Survival hinges on quality, storytelling, and innovation. Pre-rolls and edibles (projected $48.7B by 2030) gain share. Stresses margin tracking and cost control.

Looking Ahead

Disciplined operators thrive despite headwinds. Growth is selective, favoring those with strong fundamentals. Federal changes could unlock upside, but structural challenges persist.